Dual contacts between peptide agonist ligands and the secretin receptor directly established by photoaffinity labeling

被引:0
作者
Dong, MQ [1 ]
Wang, Y [1 ]
Miller, LJ [1 ]
机构
[1] Mayo Clin, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA
来源
VIP, PACAP, GLUCAGON, AND RELATED PEPTIDES | 2000年 / 921卷
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Structural analysis of secretin in solution has demonstrated extended helical domains within both amino- and carboxyl-terminal halves, with a possible turn in between. However, the conformation of this peptide as it resides in its binding site within the receptor has not been established. In the work reported here, we performed affinity labeling of the secretin receptor with radioiodinated secretin analogues having photolabile benzoyl-phenylalanine residues positioned in each half of the peptide. The probes had sites of covalent attachment in positions 6 and 22, and have been recently synthesized and characterized to represent high affinity agonist ligands. Both covalently labeled the secretin receptor in a saturable, specific, and efficient manner. After purification of the labeled receptor, we used a series of chemical and enzymatic cleavage techniques to define the domain of labeling. We complemented this by receptor mutagenesis, followed by additional cleavage and Edman degradation sequencing to refine our insights into the labeled residues. This has allowed us to demonstrate that sites of attachment were both within the extracellular aminoterminal domain of the receptor. Of particular interest, both probes labeled residues within the amino-terminal thirty residues at the distal end of the receptor. It will be particularly interesting to use these molecular approximations to model the binding domain of this important receptor.
引用
收藏
页码:381 / 386
页数:6
相关论文
共 50 条
[31]   Intrinsic photoaffinity labeling of the cholecystokinin receptor provides dual constraints for modeling the ligand-binding site. [J].
Hadac, EM ;
Pinon, DI ;
Ji, Z ;
Holicky, EL ;
Lybrand, T ;
Miller, LJ .
GASTROENTEROLOGY, 1998, 114 (04) :A466-A466
[32]   PHOTOAFFINITY-LABELING OF BENZODIAZEPINE RECEPTORS IN RAT-BRAIN WITH FLUNITRAZEPAM ALTERS THE AFFINITY OF BENZODIAZEPINE RECEPTOR AGONIST BUT NOT ANTAGONIST BINDING [J].
GEE, KW ;
YAMAMURA, HI .
JOURNAL OF NEUROCHEMISTRY, 1983, 41 (05) :1407-1413
[33]   Docking of linear peptide antagonists into the human V1a vasopressin receptor -: Identification of binding domains by photoaffinity labeling [J].
Phalipou, S ;
Seyer, R ;
Cotte, N ;
Breton, C ;
Barberis, C ;
Hibert, M ;
Mouillac, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) :23316-23327
[34]   Docking of linear peptide antagonists into the human V1a vasopressin receptor: Identification of binding domains by photoaffinity labeling [J].
U469 INSERM, 141 rue de la Cardonille, 34094 Montpellier Cedex 5, France ;
不详 ;
不详 .
J Biol Chem, 33 (23316-23327)
[35]   Importance of the amino terminus in secretin family G protein-coupled receptors - Intrinsic photoaffinity labeling establishes initial docking constraints for the calcitonin receptor [J].
Dong, MQ ;
Pinon, DI ;
Cox, RF ;
Miller, LJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (02) :1167-1175
[36]   The amino-terminal region of the luteinizing hormone choriogonadotropin receptor contacts both subunits of human choriogonadotropin II. Photoaffinity labeling [J].
Phang, T ;
Kundu, G ;
Hong, SH ;
Ji, IH ;
Ji, TH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) :13841-13847
[37]   Strategies for the design of non-peptide CCK2 receptor agonist and antagonist ligands [J].
Kalindjian, S. Barret ;
McDonald, Iain M. .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (12) :1195-1204
[38]   Characterization of non-peptide antagonist and peptide agonist binding sites of the NK1 receptor with fluorescent ligands [J].
Turcatti, G ;
Zoffmann, S ;
Lowe, JA ;
Drozda, SE ;
Chassaing, G ;
Schwartz, TW ;
Chollet, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (34) :21167-21175
[39]   Cryo-electron microscopy structure of the glucagon receptor with a dual-agonist peptide [J].
Chang, Rulue ;
Zhang, Xin ;
Qiao, Anna ;
Dai, Antao ;
Belousoff, Matthew J. ;
Tan, Qiuxiang ;
Shao, Lijun ;
Zhong, Li ;
Lin, Guangyao ;
Liang, Yi-Lynn ;
Ma, Limin ;
Han, Shuo ;
Yang, Dehua ;
Danev, Radostin ;
Wang, Ming-Wei ;
Wootten, Denise ;
Wu, Beili ;
Sexton, Patrick M. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (28) :9313-9325
[40]   Truncation of the peptide sequence in bifunctional ligands with mu and delta opioid receptor agonist and neurokinin 1 receptor antagonist activities [J].
Nair, Padma ;
Yamamoto, Takashi ;
Largent-Milnes, Tally M. ;
Cowell, Scott ;
Kulkarni, Vinod ;
Moye, Sharif ;
Navratilova, Edita ;
Davis, Peg ;
Ma, Shou-Wu ;
Vanderah, Todd W. ;
Lai, Josephine ;
Porreca, Frank ;
Hruby, Victor J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (17) :4975-4978